These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1086534)

  • 1. The effects of folic or folinic acid on the toxicity of 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(3,4-dichlorobenzyloxy)-1,3,5-triazine hydrochloride, an antifolate, in dogs.
    Lee CC; Heiffer MH; Kintner LD
    Toxicol Appl Pharmacol; 1976 Oct; 38(1):29-37. PubMed ID: 1086534
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of folic or folinic acid on the toxicity of pyrimethamine in dogs.
    Castles TR; Kintner LD; Lee CC
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):447-59. PubMed ID: 5316905
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture.
    Yeo AE; Seymour KK; Rieckmann KH; Christopherson RI
    Ann Trop Med Parasitol; 1997 Jan; 91(1):17-23. PubMed ID: 9093425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the chemotherapy of malaria. (III). Treatment of falciparum malaria in the Gambia, with BRL 50216 (4,6-diamino-(3, 4-dichlorobenzyloxy)-1,2-dihydro-2 2-dimethyl-1,3,5-triazine hydrochloride) alone and in combination with sulphonamides,
    Laing AB
    Trans R Soc Trop Med Hyg; 1974; 68(2):133-8. PubMed ID: 4617937
    [No Abstract]   [Full Text] [Related]  

  • 5. The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.
    Kinyanjui SM; Mberu EK; Winstanley PA; Jacobus DP; Watkins WM
    Am J Trop Med Hyg; 1999 Jun; 60(6):943-7. PubMed ID: 10403325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trans-stimulation effects of folic acid derivatives on methotrexate transport by rat renal organic anion transporter, OAT-K1.
    Takeuchi A; Masuda S; Saito H; Hashimoto Y; Inui K
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1034-9. PubMed ID: 10869408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Aryldihydro-s-triazines with antifolate activity II: Blood levels and their relevance to antineoplastic activity in rats.
    Upton RA; Ashley JJ; Ryan AJ
    J Pharm Sci; 1978 Mar; 67(3):310-4. PubMed ID: 641713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of the drug activity by folic or folinic acid.
    Erba E; Sen S; Sessa C; Vikhanskaya FL; D'Incalci M
    Br J Cancer; 1994 Feb; 69(2):205-11. PubMed ID: 8297715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiopulmonary effects of antimalarial drugs. V. Cycloguanil and a new triazine compound (WR 99,662).
    Ruiz R; Grigas EO; Aviado DM
    Toxicol Appl Pharmacol; 1971 Feb; 18(2):487-97. PubMed ID: 4398207
    [No Abstract]   [Full Text] [Related]  

  • 10. Dihydrofolate-mediated reversal of methotrexate toxicity to hepatoma cells in vitro.
    Kruger-McDermott C; Balinska M; Galivan J
    Cancer Lett; 1986 Jan; 30(1):79-84. PubMed ID: 3484673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium knowlesi: in vitro evaluation of antimalarial activity of folic acid inhibitors.
    McCormick GJ; Canfield CJ; Willet GP
    Exp Parasitol; 1971 Aug; 30(1):88-93. PubMed ID: 5316583
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of folic acid and folinic acid on cognitive and motor behaviors in 20-month-old rats.
    Lalonde R; Joyal CC; Botez MI
    Pharmacol Biochem Behav; 1993 Mar; 44(3):703-7. PubMed ID: 8451272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational analysis of lipophilic antifolates: crystal and molecular structures of three s-triazine dihydrofolate reductase inhibitors.
    Cody V; Sutton PA
    Anticancer Drug Des; 1987 Dec; 2(3):253-62. PubMed ID: 3449089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and inhibition analysis of 2(4)-imino-4(2)-amino-2,4-dideoxyriboflavin, a dual antagonist of riboflavin and folinic acid.
    Chu CK; Bardos TJ
    J Med Chem; 1977 Feb; 20(2):312-4. PubMed ID: 299892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the biological interrelationships of folic acid, citrovorum factor, and the antimetabolite, aminopterin.
    GOLDIN A; GREENSPAN EM; VENDITTI JM; SCHOENBACH EB
    J Natl Cancer Inst; 1952 Apr; 12(5):987-1002. PubMed ID: 14928052
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of human dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s. A quantitative structure-activity relationship analysis.
    Hathaway BA; Guo ZR; Hansch C; Delcamp TJ; Susten SS; Freisheim JH
    J Med Chem; 1984 Feb; 27(2):144-9. PubMed ID: 6694162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of folic and folinic acids on the metabolism of phenylalanine in phenylketonuria.
    Copenhaver JH; Carver MJ; Schain RJ
    Metabolism; 1965 Dec; 14(12):1233-6. PubMed ID: 5294700
    [No Abstract]   [Full Text] [Related]  

  • 18. Irreversible enzyme inhibitors. CLX. Some factors in cell wall transport of active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines.
    Baker BR; Janson EE; Vermeulen NM
    J Med Chem; 1969 Sep; 12(5):898-902. PubMed ID: 5812208
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicity and anticancer activity of a new triazine antifolate (NSC 127755).
    Corbett TH; Leopold WR; Dykes DJ; Roberts BJ; Griswold DP; Schabel FM
    Cancer Res; 1982 May; 42(5):1707-15. PubMed ID: 7066891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2, 4-Diaminopyrimidines as antagonists of folic acid and folinic acid.
    HITCHINGS GH; FALCO EA; ELION GB; SINGER S; WARING GB; HUTCHISON DJ; BURCHENAL JH
    Arch Biochem Biophys; 1952 Oct; 40(2):479-81. PubMed ID: 12997239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.